Medication info
Monospin Tablet 40 mg (Telmisartan)

Monospin Tablet 40 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
Bionex Co., Ltd.
Appearance
White oval-shaped tablet
Packaging
30 tablets/box [10 tablets/PTP × 3], 30 tablets/bottle
Approval status
Active

MFDS item code 201603838 · Approved 2016.06.23 · Insurance code 643104740

Summary

Main use
Treatment of essential hypertension; reduction and prevention of cardiovascular disease risk in high-risk patients
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan 40 mg should be taken orally once daily with water, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When increasing the dose, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after initiation of treatment. This drug produces an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this drug be administered orally at a dose of 80 mg once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this drug for the purpose of reducing cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Bionex Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; reduction and prevention of cardiovascular disease risk in high-risk patients

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • evidence of end-organ damage in patients with high-risk diabetes
View approved original text

This medication helps control blood pressure in patients with essential hypertension. It is also effective in reducing the risk of myocardial infarction, stroke, and death due to cardiovascular diseases in individuals who cannot use ACE inhibitors and are at high risk of cardiovascular diseases. It plays an important role in patients over 55 years of age with coronary artery disease, peripheral artery disease, stroke, or high-risk diabetes. This medication is used not only for blood pressure management but also for improving cardiovascular health.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan 40 mg should be taken orally once daily with water, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When increasing the dose, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after initiation of treatment. This drug produces an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this drug be administered orally at a dose of 80 mg once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this drug for the purpose of reducing cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. People who have an allergic reaction to this drug or its components, those who are pregnant or breastfeeding, patients with severe liver disorders or biliary obstruction, individuals with hereditary angioedema, and those with diabetes or severe renal impairment should not take this medication. Elderly patients, those with high potassium levels, liver dysfunction patients, specific heart conditions, and renal artery hypertension patients should use this drug cautiously, as there may be increased risks of side effects depending on concurrent medications. This drug lowers blood pressure and may cause hypotension, dizziness, or fainting, so symptoms should be closely monitored while taking it. Serum potassium levels may increase, so patients at risk of hyperkalemia require regular blood tests. Various side effects such as liver dysfunction, renal function deterioration, angioedema, allergic reactions, gastrointestinal disturbances, myalgia, etc., may occur, and if abnormal symptoms arise, immediate consultation with a healthcare professional is necessary. Interactions may occur if taken with other antihypertensives or specific medications, so it is essential to inform healthcare professionals of any current medications. This medication is not recommended for children as safety and efficacy have not been established, and caution should be exercised in elderly patients to avoid excessive lowering of blood pressure. In cases of overdose, serious symptoms such as hypotension and acute renal failure may occur, requiring immediate medical attention. This drug should be kept out of reach of children and should be taken in its fresh state after opening the package. Caution is needed when driving or operating machinery due to the risk of dizziness or fainting. Women planning to become pregnant or who might be pregnant should consult with their healthcare professional before taking this medication, and breastfeeding women are advised to avoid it.

Side effects

  • Upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 97 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distention
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbance
  • liver function impairment
  • liver disorder
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • low back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute kidney failure
  • chest pain
  • asthenia
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • increased liver enzymes
  • elevated serum creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • weakness
  • hunger
  • cold sweat
  • tremor
  • decreased concentration
  • convulsion
  • altered consciousness
  • facial swelling
  • lip swelling
  • pharyngeal and laryngeal swelling
  • tongue swelling
  • severe hyperkalemia
  • renal failure
  • shock
  • loss of consciousness
  • jaundice
  • dyspnea
  • hypotension
  • laryngeal edema
  • fever
  • pneumonia
  • myalgia
  • elevated creatine kinase
  • increased serum myoglobin
  • increased urinary myoglobin
  • palpitations
  • fatigue
  • nausea
  • insufficient effect
  • headache
  • dizziness
  • cough
  • dyspepsia
  • edema
  • decreased libido
  • facial edema
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly closed container to protect it from air and moisture, at a temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the drug's efficacy and safety.

Appearance and packaging

Appearance

White oval-shaped tablet

Package unit

30 tablets/box [10 tablets/PTP × 3], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.